Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Diogo Teixeira Pereira, Catherine Moury & Pedro Pita Barros. (2023) Business as usual? How the pharmaceutical industry protected its long-term interests during and after eurozone bailouts (2011–2020). Political Research Exchange 5:1.
Read now
Read now
Louise Curran & Jappe Eckhardt. (2017) Smoke screen? The globalization of production, transnational lobbying and the international political economy of plain tobacco packaging. Review of International Political Economy 24:1, pages 87-118.
Read now
Read now
Alexandre Bohas. (2015) Neopluralism and globalization: the plural politics of the Motion Picture Association. Review of International Political Economy 22:6, pages 1188-1216.
Read now
Read now
Kristen Hopewell. (2015) Different paths to power: The rise of Brazil, India and China at the World Trade Organization. Review of International Political Economy 22:2, pages 311-338.
Read now
Read now
Rory Horner. (2014) The Impact of Patents on Innovation, Technology Transfer and Health: A Pre- and Post-TRIPs Analysis of India's Pharmaceutical Industry. New Political Economy 19:3, pages 384-406.
Read now
Read now
Articles from other publishers (24)
Laura Gatto. (2023) Coping with a crisis: business interest group coalitions in the wake of the financial crisis. Interest Groups & Advocacy 12:3, pages 297-321.
Crossref
Crossref
Obi Peter Adigwe & Davidson Oturu. (2022) The role of patent waivers and compulsory licensing in facilitating access to COVID-19 vaccines: Findings from a survey among healthcare practitioners in Nigeria. PLOS Global Public Health 2:7, pages e0000683.
Crossref
Crossref
David Brenner & Martina Tazzioli. (2022) Defending Society, Building the Nation: Rebel Governance as Competing Biopolitics. International Studies Quarterly 66:2.
Crossref
Crossref
Madison Cartwright. (2019) Business conflict and international law: The political economy of copyright in the United States. Regulation & Governance 15:1, pages 152-167.
Crossref
Crossref
Manuel Martínez-Blanes, Francisco Javier Rondán-Cataluña & José Manuel Velarde-Gestera. (2020) Indicators of Efficiency in the Pharmaceutical Management of a Public Health System. Administrative Sciences 10:2, pages 31.
Crossref
Crossref
JACOB MUIRHEAD & TONY PORTER. (2019) Traceability in global governance. Global Networks 19:3, pages 423-443.
Crossref
Crossref
Rory Horner. 2019. Business Responsibility and Sustainability in India. Business Responsibility and Sustainability in India
275
304
.
Kees Jansen. (2017) Business Conflict and Risk Regulation: Understanding the Influence of the Pesticide Industry. Global Environmental Politics 17:4, pages 48-66.
Crossref
Crossref
Haritz Gorostidi-Martinez & Xiaokang Zhao. (2017) Corporate political strategies: a contemporary literature review. Journal of Advances in Management Research 14:3, pages 375-404.
Crossref
Crossref
Kevin Young & Stefano Pagliari. (2017) Capital united? Business unity in regulatory politics and the special place of finance. Regulation & Governance 11:1, pages 3-23.
Crossref
Crossref
Ludek Stavinoha. (2016) Losing the media battle, waging the policy war: The pharmaceutical industry’s response to the access to medicines crisis in the Global South. Global Media and Communication 12:3, pages 275-294.
Crossref
Crossref
Chon Kit Chao, Hao Hu, Liming Zhang & Jihong Wu. (2016) Managing the challenges of pharmaceutical patent expiry: a case study of Lipitor. Journal of Science and Technology Policy Management 7:3, pages 258-272.
Crossref
Crossref
Rory Horner. (2016) Pharmaceuticals and the Global South: A Healthy Challenge for Development Theory?. Geography Compass 10:9, pages 363-377.
Crossref
Crossref
Yrd. Doç. Dr. Yaşar Serhat YAŞGÜL. (2016) Türkiye’de İlaç İthalatını Belirleyen Etmenler, 1996-2011. Anadolu Üniversitesi Sosyal Bilimler Dergisi 16:2, pages 21-36.
Crossref
Crossref
Ethan B. Kapstein & Joshua William Busby. (2016) Social Movements and Market Transformations: Lessons From HIV/AIDS and Climate Change: Table 1.. International Studies Quarterly 60:2, pages 317-329.
Crossref
Crossref
Rory Horner. (2015) Responding to the rising power “threat”. critical perspectives on international business 11:3/4, pages 285-300.
Crossref
Crossref
Nitsan Chorev & Kenneth C. Shadlen. (2015) Intellectual Property, Access to Medicines, and Health: New Research Horizons. Studies in Comparative International Development 50:2, pages 143-156.
Crossref
Crossref
Hosein Shabaninejad, Gholamhossein Mehralian, Arash Rashidian, Ahmad Baratimarnani & Hamid Reza Rasekh. (2014) Identifying and prioritizing industry-level competitiveness factors: evidence from pharmaceutical market. DARU Journal of Pharmaceutical Sciences 22:1.
Crossref
Crossref
ANNE ROEMER-MAHLER. (2014) The rise of companies from emerging markets in global health governance: Opportunities and challenges. Review of International Studies 40:5, pages 897-918.
Crossref
Crossref
Brett Christophers. (2014) On the Performativity of Pill Pricing: Theory and Reality in the Economics of Global Pharmaceuticalization. Antipode 46:4, pages 1054-1071.
Crossref
Crossref
Kelley Lee & Adam Kamradt-Scott. (2014) The multiple meanings of global health governance: a call for conceptual clarity. Globalization and Health 10:1, pages 28.
Crossref
Crossref
Verena Schüren. (2017) What a difference a state makes: pharmaceutical innovation after the TRIPs agreement. Business and Politics 15:2, pages 217-243.
Crossref
Crossref
Jason Miklian & Angelika Rettberg. (2017) From War-Torn to Peace-Torn? Mapping Business Strategies in Transition from Conflict to Peace in Colombia. SSRN Electronic Journal.
Crossref
Crossref
Toby Seddon. (2011) Regulating Global Drug Problems. SSRN Electronic Journal.
Crossref
Crossref